AmerisourceBergen Corporation

AmerisourceBergen Corporation

ABC
AmerisourceBergen CorporationUS flagNew York Stock Exchange
179.98
USD
-0.41
- -
36.15BMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

CEO
Steven H. Collis
Full Time Employees
46,000
Sector
Healthcare
Industry
Medical - Distribution
Address
1 West First Avenue Conshohocken PA United States of America 19428-1800
IPO Date
Apr 4, 1995
Business
Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, operates as a global leader in pharmaceutical sourcing, distribution, and healthcare solutions, serving manufacturers, providers, pharmacies, and patients worldwide. The company distributes pharmaceuticals including generic and brand-name drugs, specialty injectables, over-the-counter healthcare products, home healthcare supplies and equipment; provides pharmacy automation, management, staffing, and consulting services; offers data analytics, outcomes research, reimbursement support, logistics, inventory management, packaging solutions, and supply chain software; and delivers animal health products through MWI Animal Health such as vaccines, parasiticides, diagnostics, and micro feed ingredients to companion and production animal markets. Its U.S. Healthcare Solutions segment targets acute care hospitals, health systems, independent and chain retail pharmacies, mail-order pharmacies, medical clinics, long-term care facilities, physician practices, dialysis centers, and veterinarians; the International Healthcare Solutions segment supplies pharmaceuticals and services to pharmacies, doctors, health centers, and hospitals across more than 75 countries via Alliance Healthcare; and additional capabilities encompass global commercialization services through World Courier, clinical trial support, product post-approval services, provider and pharmacy solutions, hospital systems optimization, drug research support, patient access and adherence programs, and biopharma commercialization. Founded through the 2001 merger of AmeriSource Health Corporation and Bergen Brunswig Corporation with roots tracing to 1871, Cencora maintains headquarters in Conshohocken, Pennsylvania. In recent developments, the company rebranded from AmerisourceBergen to Cencora in August 2023 to unify its global identity and emphasize innovation in pharmaceutical services; completed the $4.6 billion acquisition of Retina Consultants of America (RCA), a retina specialty management services organization, in January 2025 to bolster its specialty medicine footprint; entered a joint venture with TPG in 2023 to acquire OneOncology for enhanced oncology support; acquired PharmaLex in 2022 to expand biopharma services; transitioned animal health branding under Cencora in January 2025; and reported strong fiscal 2025 results with focus on working capital efficiency amid regulatory and cyber challenges.

Company News

  • Disney's ABC Sues FCC And Can Lean On Decades Of Deregulation

  • ABC Local Station Move Draws FCC Scrutiny

  • Now Streaming: Paramount says it satisfied regulatory approvals for Warner deal

  • ABC says intimidation by Trump's FCC forced programming changes

  • Disney just sued the Trump administration over an ‘unprecedented' move against ABC

  • Wall Street Lunch: Meta Faces High-Stakes Federal Trial Over Child Safety

  • Disney Sues FCC, Alleging Retaliation Against ABC

  • Disney's ABC sues FCC over Trump admin's alleged ‘retaliatory campaign' to silence its lefty shows

  • Disney-owned ABC files First Amendment lawsuit against FCC

  • ABC Sues Trump Administration Over Alleged ‘Retaliatory Campaign'

  • Disney, ABC sue US regulator over threats to broadcast licenses

  • Disney's ABC Sues FCC Over Challenge to Its Broadcast Licenses

  • From ABC To Abu Dhabi, Bob Iger Changed Disney Forever

  • FCC commissioner says Trump call to revoke ABC, NBC licenses is unconstitutional

  • ‘The View' faces trouble as FCC prepares to crack down on ABC show, revoke Disney licenses: report

  • ABC Launches On-Air Campaign Against FCC Investigations

  • Suncrete, Inc. Completes Arkansas Acquisition

  • Meta, ABC Form Partnership to Launch Academy to Train and Create Jobs for Construction Craft Professionals

  • Nexstar Television Stations Win 34 Regional Edward R. Murrow Awards for Outstanding Journalism and Exceptional Locally Produced News

  • Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6